The Role of Neoadjuvant Chemotherapy in NSCLC
- 1 May 1996
- Vol. 109 (5) , 93S-95S
- https://doi.org/10.1378/chest.109.5_supplement.93s
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Chemotherapy for Resectable Stage III Non--Small-Cell Lung Cancer--Can That Dog Hunt?JNCI Journal of the National Cancer Institute, 1994
- A Randomized Trial Comparing Perioperative Chemotherapy and Surgery With Surgery Alone in Resectable Stage IIIA Non-Small-Cell Lung CancerJNCI Journal of the National Cancer Institute, 1994
- Neoadjuvant Cisplatin and Etoposide for Stage IIIA (Clinical N2) Non-Small Cell Lung CancerAmerican Journal of Clinical Oncology, 1994
- Neoadjuvant Treatment of Stage IIIA Non-Small Cell Lung Cancer Long-Term ResultsAmerican Journal of Clinical Oncology, 1994
- A Randomized Trial Comparing Preoperative Chemotherapy Plus Surgery with Surgery Alone in Patients with Non-Small-Cell Lung CancerNew England Journal of Medicine, 1994
- Induction chemotherapy for locally advanced non-small cell lung cancerThe Annals of Thoracic Surgery, 1993
- Multimodality Therapy for Stage IIIA (N2) Lung CancerChest, 1993
- Multimodality treatment of stage IIIA non-small-cell lung carcinoma: a critical review of the literature and strategies for future research.Journal of Clinical Oncology, 1992
- Induction therapy for NSCLC: a consensus reportLung Cancer, 1991
- Lung cancer classification: The relationship of disease extent and cell type to survival in a clinical trials populationJournal of Surgical Oncology, 1987